Related Experiment Video
Updated: Jun 26, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Protein palmitoylation regulates osteoblast differentiation through BMP-induced osterix expression
Wai Fook Leong1, Tielin Zhou, Gek Liang Lim
1Cancer and Developmental Biology Division, The Institute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.
Protein palmitoylation is crucial for osteoblast differentiation and bone formation. Inhibiting this process reduces osterix expression and impairs bone development, suggesting new therapeutic targets for osteoporosis.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- Osteoporosis is a prevalent bone disease requiring novel therapeutic targets.
- Understanding osteoblast biology, including proliferation, differentiation, and function, is key to developing anabolic drugs.
- Protein palmitoylation is a post-translational modification with potential roles in cellular signaling.
Purpose of the Study:
- To investigate the role of protein palmitoylation in osteoblast differentiation and identify its involvement in signaling pathways regulating osterix expression.
- To explore protein palmitoylation as a potential therapeutic target for osteoporosis.
Main Methods:
- Utilized mouse calvarial osteoblasts to study protein palmitoylation.
- Employed a substrate-analog inhibitor to block protein palmitoylation.
- Assessed osteoblast proliferation, survival, differentiation, and mineralization.
- Analyzed the expression of key transcription factors like osterix, Runx2, and Atf4.
- Investigated the impact on BMP2-induced differentiation and associated signaling pathways (MAPK, Smad).
Main Results:
- Protein palmitoylation is expressed in mouse osteoblasts, with some enzymes upregulated during differentiation.
- Inhibition of protein palmitoylation reduced osteoblast differentiation and mineralization but not proliferation or survival.
- Reduced differentiation correlated with decreased osterix expression, but not Runx2 or Atf4.
- The effect of palmitoylation inhibition on differentiation was partially mediated by osterix.
- Palmitoylation inhibition compromised BMP2-induced differentiation by downregulating osterix induction.
- Inhibition affected p38 MAPK activation but not Smad1/5/8 activation, indicating a role in BMP-induced MAPK signaling.
Conclusions:
- Protein palmitoylation is essential for osteoblast differentiation and mineralization.
- It plays a critical role in regulating osterix expression, partly through BMP-induced MAPK activation.
- Targeting protein palmitoylation pathways may offer a novel therapeutic strategy for osteoporosis.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Bone Remodeling
TGF - β Signaling Pathway
Bone Formation by Endochondral Ossification
Master Transcription Regulators
